|
ZNF570 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.67500466222259E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.97729651832901E-11 |
| Normal-vs-Stage2 |
1.05979999998063E-07 |
| Normal-vs-Stage3 |
1.63380420303838E-11 |
| Normal-vs-Stage4 |
8.28981328027112E-12 |
| Stage1-vs-Stage2 |
6.878000E-01 |
| Stage1-vs-Stage3 |
3.136000E-01 |
| Stage1-vs-Stage4 |
1.237180E-01 |
| Stage2-vs-Stage3 |
3.110200E-01 |
| Stage2-vs-Stage4 |
1.792440E-01 |
| Stage3-vs-Stage4 |
6.029000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63810084888405E-11 |
| Normal-vs-AfricanAmerican |
8.08370000000558E-05 |
| Normal-vs-Asian |
3.10830028382725E-10 |
| Caucasian-vs-AfricanAmerican |
2.953400E-01 |
| Caucasian-vs-Asian |
6.257200E-01 |
| AfricanAmerican-vs-Asian |
2.225200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.80729883783692E-11 |
| Normal-vs-Female |
4.12500034130403E-11 |
| Male-vs-Female |
6.028800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.3106005170016E-10 |
| Normal-vs-Age(41-60Yrs) |
2.27640128969142E-11 |
| Normal-vs-Age(61-80Yrs) |
4.92605956026182E-12 |
| Normal-vs-Age(81-100Yrs) |
3.063100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.054000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.565800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.932600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.067800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.424200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.865400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.056800E-03 |
| Classical-VS-Follicular |
2.813000E-01 |
| Classical-VS-Other |
9.933700E-02 |
| Classical-VS-Normal |
8.22309997872139E-10 |
| Tall-VS-Follicular |
7.159500E-02 |
| Tall-VS-Other |
6.494200E-01 |
| Tall-VS-Normal |
3.39384076397664E-12 |
| Follicular-VS-Other |
2.486600E-01 |
| Follicular-VS-Normal |
1.71580527563719E-11 |
| Other-VS-Normal |
1.790060E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-15 |
| Normal-vs-N1 |
7.72493180534184E-13 |
| N0-vs-N1 |
6.179500E-02 |
|
|
